Orchestra BioMed Holdings Inc
Orchestra BioMed Holdings Inc (OBIO) Wheel Strategy
OBIO wheel strategy scan found 2 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 45.6%.
Read more
Running a OBIO wheel strategy lets you generate consistent premium income on Orchestra BioMed Holdings Inc while setting your own entry and exit prices on the underlying. Orchestra BioMed Holdings Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own OBIO, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best OBIO wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on OBIO, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable OBIO wheel from a losing one.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease.
Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the OBIO wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your OBIO wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 5.00 | $0.05 | $0.35 | -0.24 | 56 | 12% | 63.7% | 45.6% | 263 |
| Feb 19, 2027 | 5.00 | $0.15 | $0.68 | -0.27 | 147 | 12% | 52.4% | 33.5% | 40 |
As of September 25, 2026
Run the Wheel on OBIO With Confidence
Find the best OBIO wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→